Skip to main content
Figure 1 | Journal of Inflammation

Figure 1

From: P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis

Figure 1

The p38 inhibitors SB-203580 and VX-745 significantly inhibited the severity of iodoacetate-induced knee degeneration in rats. The severity of knee degeneration in rats injected with 0.25 mg of iodoacetate was evaluated 3 weeks after treatment with either vehicle (0.5% carboxymethylcellulose/0.5% Tween 20), 50 mg/kg bid of SB-203580 or VX-745 orally. The data are expressed as the mean ± S.E.M. from 15 rats per treatment group. * denotes P < 0.05.

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us